v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Common Stock
At Market Offering
Additional Paid-in Capital
Additional Paid-in Capital
At Market Offering
Accumulated Other Comprehensive (Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023   6,503,913          
Beginning balance at Dec. 31, 2023 $ 225,829 $ 0   $ 807,158   $ (348) $ (580,981)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation 4,515     4,515      
Net loss (24,302)           (24,302)
Other comprehensive loss (215)         (215)  
Ending balance (in shares) at Mar. 31, 2024   6,503,913          
Ending balance at Mar. 31, 2024 205,827 $ 0   811,673   (563) (605,283)
Beginning balance (in shares) at Dec. 31, 2023   6,503,913          
Beginning balance at Dec. 31, 2023 225,829 $ 0   807,158   (348) (580,981)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss (39,219)            
Ending balance (in shares) at Jun. 30, 2024   6,503,913          
Ending balance at Jun. 30, 2024 195,019 $ 0   815,846   (627) (620,200)
Beginning balance (in shares) at Mar. 31, 2024   6,503,913          
Beginning balance at Mar. 31, 2024 205,827 $ 0   811,673   (563) (605,283)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation 4,173     4,173      
Net loss (14,917)           (14,917)
Other comprehensive loss (64)         (64)  
Ending balance (in shares) at Jun. 30, 2024   6,503,913          
Ending balance at Jun. 30, 2024 $ 195,019 $ 0   815,846   (627) (620,200)
Beginning balance (in shares) at Dec. 31, 2024 6,525,887 6,525,887          
Beginning balance at Dec. 31, 2024 $ 169,436 $ 0   824,780   (228) (655,116)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock upon exercise of stock options (in shares)   33,040,000          
Issuance of common stock upon exercise of stock options 404     404      
Stock-based compensation 3,495     3,495      
Net loss (28,200)           (28,200)
Other comprehensive loss (223)         (223)  
Ending balance (in shares) at Mar. 31, 2025   6,558,927          
Ending balance at Mar. 31, 2025 $ 144,912 $ 0   828,679   (451) (683,316)
Beginning balance (in shares) at Dec. 31, 2024 6,525,887 6,525,887          
Beginning balance at Dec. 31, 2024 $ 169,436 $ 0   824,780   (228) (655,116)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss $ (49,594)            
Ending balance (in shares) at Jun. 30, 2025 6,750,716 6,750,716          
Ending balance at Jun. 30, 2025 $ 131,670 $ 0   837,185   (805) (704,710)
Beginning balance (in shares) at Mar. 31, 2025   6,558,927          
Beginning balance at Mar. 31, 2025 144,912 $ 0   828,679   (451) (683,316)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock upon exercise of stock options (in shares)   5,952          
Issuance of common stock upon exercise of stock options 71     71      
Issuance of common stock in at-the-market offering, net of $0.3 million in issuance costs (in shares)     185,837        
Issuance of common stock in at-the-market offering, net of $0.3 million in issuance costs 6,611       $ 6,611    
Stock-based compensation 1,824     1,824      
Net loss (21,394)           (21,394)
Other comprehensive loss $ (354)         (354)  
Ending balance (in shares) at Jun. 30, 2025 6,750,716 6,750,716          
Ending balance at Jun. 30, 2025 $ 131,670 $ 0   $ 837,185   $ (805) $ (704,710)